top of page

PARTNERSHIPS

We believe in the power of partnerships. We believe that collaboration is key to accelerating the development of innovative and life-saving therapies. Through partnerships, collaboration and strategic alliances we will develop safe and effective therapies for some of the most debilitating diseases. Leveraging our library of novel new class of Peptide Conjugate Nanosystems (PCN) and innovative proprietary technology platforms we are developing first in class therapies for central nervous system diseases and other disorders by delivering next generation advanced therapies.

Scientist on Computer

Science

Learn more about our Therapeutic Platforms

Scientist

Partners

We are partnering with researchers from across the world to find safe and effective therapies for debilitating diseases.

DELIVERING LIFE SAVING THERAPIES,

OVERCOMING BARRIERS

Our approach is different. We have designed and optimised effective and versatile delivery platform technologies along with a library of new class of nanoparticles. We have also focused on designing the next generation therapeutics expanding our discovery Programmes.

If you are interested in partnering with us to deliver the next generation of 21st century therapies, contact us today.

SMDG collaborates with researchers at companies, universities and non- profit organisations on innovative and therapeutic projects – a few examples
Global Collaborations_29102023.png
bottom of page